NASDAQ:AMSF

AMERISAFE (AMSF) Stock Price, News & Analysis

$47.49
-0.12 (-0.25%)
(As of 05:26 PM ET)
Today's Range
$47.47
$47.92
50-Day Range
$44.98
$53.33
52-Week Range
$44.61
$56.84
Volume
55,411 shs
Average Volume
131,552 shs
Market Capitalization
$908.72 million
P/E Ratio
14.79
Dividend Yield
3.12%
Price Target
$65.00

AMERISAFE MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
36.9% Upside
$65.00 Price Target
Short Interest
Healthy
1.79% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
1.30mentions of AMERISAFE in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-13.06%
From $2.45 to $2.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.10 out of 5 stars

Finance Sector

273rd out of 874 stocks

Fire, Marine, & Casualty Insurance Industry

19th out of 53 stocks

AMSF stock logo

About AMERISAFE Stock (NASDAQ:AMSF)

AMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. AMERISAFE, Inc. was incorporated in 1985 and is based in DeRidder, Louisiana.

AMSF Stock Price History

AMSF Stock News Headlines

AMERISAFE (NASDAQ:AMSF) Lowered to Sell at StockNews.com
Could this Tiny Biotech End Disease Forever?
Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.
AMERISAFE (NASDAQ:AMSF) Stock Rating Lowered by StockNews.com
Q1 2024 Amerisafe Inc Earnings Call
AMERISAFE declares $0.37 dividend
Could this Tiny Biotech End Disease Forever?
Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.
AMERISAFE Announces 2024 First Quarter Results
Amerisafe earnings: here's what Wall Street expects
AMSF Jul 2024 55.000 call
AMSF Apr 2024 50.000 call
AMSF Oct 2024 55.000 call
AMSF Jul 2024 46.500 put
Are Finance Stocks Lagging AMERISAFE (AMSF) This Year?
AIG Mar 2024 70.000 put
AMERISAFE (NASDAQ:AMSF) Has Announced A Dividend Of $0.37
AMERISAFE Full Year 2023 Earnings: Beats Expectations
See More Headlines
Receive AMSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMERISAFE and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/22 Dividend
3/07/2024
Dividend Payable
3/22/2024
Last Earnings
4/25/2024
Today
5/08/2024
Ex-Dividend for 6/21 Dividend
6/14/2024
Dividend Payable
6/21/2024
Next Earnings (Estimated)
7/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Fire, marine, & casualty insurance
Sub-Industry
Property & Casualty Insurance
Current Symbol
NASDAQ:AMSF
CUSIP
03071H10
Employees
350
Year Founded
1985

Price Target and Rating

Average Stock Price Target
$65.00
High Stock Price Target
$65.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+36.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$62.11 million
Pretax Margin
24.79%

Debt

Sales & Book Value

Annual Sales
$306.85 million
Cash Flow
$3.19 per share
Book Value
$15.25 per share

Miscellaneous

Free Float
18,831,000
Market Cap
$914.51 million
Optionable
Optionable
Beta
0.35

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


AMSF Stock Analysis - Frequently Asked Questions

Should I buy or sell AMERISAFE stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AMERISAFE in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AMSF shares.
View AMSF analyst ratings
or view top-rated stocks.

What is AMERISAFE's stock price target for 2024?

1 analysts have issued 12-month price objectives for AMERISAFE's shares. Their AMSF share price targets range from $65.00 to $65.00. On average, they predict the company's share price to reach $65.00 in the next twelve months. This suggests a possible upside of 36.9% from the stock's current price.
View analysts price targets for AMSF
or view top-rated stocks among Wall Street analysts.

How have AMSF shares performed in 2024?

AMERISAFE's stock was trading at $46.78 at the beginning of 2024. Since then, AMSF stock has increased by 1.5% and is now trading at $47.49.
View the best growth stocks for 2024 here
.

Are investors shorting AMERISAFE?

AMERISAFE saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 337,800 shares, an increase of 9.1% from the March 31st total of 309,700 shares. Based on an average trading volume of 140,500 shares, the days-to-cover ratio is currently 2.4 days. Currently, 1.8% of the shares of the company are short sold.
View AMERISAFE's Short Interest
.

When is AMERISAFE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our AMSF earnings forecast
.

How were AMERISAFE's earnings last quarter?

AMERISAFE, Inc. (NASDAQ:AMSF) issued its earnings results on Thursday, April, 25th. The insurance provider reported $0.69 EPS for the quarter, beating the consensus estimate of $0.66 by $0.03. The insurance provider had revenue of $80.49 million for the quarter, compared to analyst estimates of $75.22 million. AMERISAFE had a trailing twelve-month return on equity of 16.76% and a net margin of 19.97%. During the same period last year, the business earned $0.83 earnings per share.

How often does AMERISAFE pay dividends? What is the dividend yield for AMERISAFE?

AMERISAFE announced a quarterly dividend on Wednesday, April 24th. Shareholders of record on Friday, June 14th will be paid a dividend of $0.37 per share on Friday, June 21st. This represents a $1.48 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date of this dividend is Friday, June 14th.
Read our dividend analysis for AMSF
.

Is AMERISAFE a good dividend stock?

AMERISAFE (NASDAQ:AMSF) pays an annual dividend of $1.48 per share and currently has a dividend yield of 3.14%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 46.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AMSF will have a dividend payout ratio of 69.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for AMSF.

What ETFs hold AMERISAFE's stock?

ETFs with the largest weight of AMERISAFE (NASDAQ:AMSF) stock in their portfolio include Invesco S&P SmallCap Low Volatility ETF (XSLV).iShares U.S. Insurance ETF (IAK).

What is Janelle Frost's approval rating as AMERISAFE's CEO?

28 employees have rated AMERISAFE Chief Executive Officer Janelle Frost on Glassdoor.com. Janelle Frost has an approval rating of 79% among the company's employees. 30.0% of employees surveyed would recommend working at AMERISAFE to a friend.

What other stocks do shareholders of AMERISAFE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AMERISAFE investors own include Rollins (ROL), BioDelivery Sciences International (BDSI), Cronos Group (CRON), Quotient Technology (QUOT), Dominion Energy (D), AT&T (T), Bristol-Myers Squibb (BMY), CenterPoint Energy (CNP), Invesco (IVZ) and Altria Group (MO).

Who are AMERISAFE's major shareholders?

AMERISAFE's stock is owned by a number of retail and institutional investors. Top institutional shareholders include New South Capital Management Inc. (1.08%), Isthmus Partners LLC (0.35%), Assenagon Asset Management S.A. (0.18%), Texas Permanent School Fund Corp (0.09%), Mirae Asset Global Investments Co. Ltd. (0.08%) and BNP Paribas Financial Markets (0.06%). Insiders that own company stock include Anastasios Omiridis, Andrew B Mccray, G Janelle Frost, Kathryn Housh Shirley, Kevin T Hogan, Neal Andrew Fuller, Philip A Garcia, Philip A Garcia, Sean Traynor and Vincent J Gagliano.
View institutional ownership trends
.

How do I buy shares of AMERISAFE?

Shares of AMSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AMSF) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners